🇺🇸 FDA
Patent

US 10072022

Oridonin analogs, compositions, and methods related thereto

granted A61PA61P35/00

Quick answer

US patent 10072022 (Oridonin analogs, compositions, and methods related thereto) held by The Board of Regents of the University of Texas System expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P35/00